Lack Of Effect Of Chromium Supplementation On Mental State And Body Weight In People With Schizophrenia
Notes for this study:
|Number of Subjects
||18-29, 30-44, 45-64
The addition of 400 µg chromium (as picolinate) to antipsycotic therapy in a small sample of schizophrenic persons over three months failed to significantly influence symptoms of schizophrenia relative to control as assessed by PANSS and HAM-D rating scales.